Androgen insensitivity syndrome

Androgen insensitivity syndrome
Testosterone (structure pictured) and dihydrotestosterone to a lesser degree, are the primary androgens involved in AIS.
ICD-10	E34.5
ICD-9	259.5
OMIM	312300 300068
DiseasesDB	29662 12975
MeSH	D013734

Androgen insensitivity syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Androgen insensitivity syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Androgen insensitivity syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Androgen insensitivity syndrome All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Androgen insensitivity syndrome
CDC on Androgen insensitivity syndrome
Androgen insensitivity syndrome in the news
Blogs on Androgen insensitivity syndrome</small>
Directions to Hospitals Treating Androgen insensitivity syndrome
Risk calculators and risk factors for Androgen insensitivity syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

• 17-hydroxylase deficiency syndrome
• 3-beta-hydroxysteroid dehydrogenase deficiency
• 5-alpha-reductase deficiency
• Congenital adrenal hyperplasia
• Mayer-rokitansky syndrome

androgen at NIH/UW GeneTests

de:Komplette Androgenresistenzit:Sindrome di Morris